44 charts that explain markets and the economy right now

Paris - Delayed Quote EUR

namR Société anonyme (ALNMR.PA)

Compare

0.3310

-0.0140

(-4.06%)

At close: January 31 at 5:16:22 PM GMT+1

Tariffs, Amazon earnings, Jobs data: What to Watch next week

Asking for a Trend host Josh Lipton previews next week's top market (^DJI, ^IXIC, ^GSPC) events. The market and economical impacts of President Donald Trump's tariffs, set to be implemented on February 1, will be closely monitored. A wave of high-profile earnings reports is scheduled next week, featuring tech and media giants, such as Palantir (PLTR), Alphabet (GOOGL, GOOG), Advanced Micro Devices (AMD), Novo Nordisk (NVO), Disney (DIS), and Amazon (AMZN). The labor market will take center stage with Job Opening and Labor Turnover Survey (JOLTS) data due out on Tuesday, followed by Friday's jobs report. Economists anticipate the addition of 150,000 nonfarm payroll jobs in January. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here. This post was written by Angel Smith

Yahoo Finance Video 20 hours ago

GOOG

NONOF

NVO
3 Reasons to Buy Dollar General Stock Like There's No Tomorrow

2024 was a rough year for Dollar General (NYSE: DG). During a year when the S&P 500 jumped 23%, shares of the discount retailer fell 44%. Profits were down at Dollar General as it faced headwinds from weak consumer spending and inflation, competition from Walmart, and operational missteps.

Motley Fool 2 hours ago

DG

^GSPC

WMT
Could Buying fuboTV Stock Today Set You Up for Life?

Just a few days later, Walt Disney (NYSE: DIS) decided to buy the company. A buyout usually spells the end of the target company's future on the stock market, after all. There couldn't be any room for game-changing stock returns after the immediate price surge.

Motley Fool 4 hours ago

FUBO

DIS
What Analysts Think of Disney Stock Ahead of Earnings

The Walt Disney Co. is set to report fiscal 2025 first-quarter results Wednesday morning, with analysts expecting rising revenue and net income as the profitability of the entertainment giant's streaming business remains a focus.

Investopedia 5 hours ago

DIS
Altria Group price target lowered to $53 from $54 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Altria Group (MO) to $53 from $54 and keeps an Equal Weight rating on the shares. Shares closed down about 2% following Altria’s slight Q4 EPS beat, soft 2025 guidance, and the unfavorable NJOY patent litigation ruling, the analyst noted. The firm cites continued elevated Smokable volume declines and a limited reduced-risk portfolio, exacerbated by the NJOY litigation loss, offset by Altria’s “solid financial flexibility,” for its Equal Weight ra

TipRanks 6 hours ago

PM

MO
3 Top Dividend Stocks I Plan to Buy in My Retirement Account in February

The thesis is simple: Dividend stocks have historically outperformed non-dividend payers by more than 2-to-1 over the past 50 years and have been much less volatile. VICI Properties (NYSE: VICI), Medtronic (NYSE: MDT), and Enbridge (NYSE: ENB) certainly meet those criteria.

Motley Fool 7 hours ago

MDT

VICI

EBGEF
Is Johnson & Johnson (JNJ) the Best Defensive Stock to Buy Right Now?

We recently published a list of 12 Best Defensive Stocks To Buy Right Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best defensive stocks to buy right now. A notable event influencing current market sentiment is the recent selloff in technology stocks, primarily driven […]

Insider Monkey 7 hours ago

JNJ

^GSPC
A Look At The Fair Value Of The Walt Disney Company (NYSE:DIS)

Key Insights The projected fair value for Walt Disney is US$123 based on 2 Stage Free Cash Flow to Equity With US$113...

Simply Wall St. 7 hours ago

DIS
Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around?

Johnson & Johnson (NYSE: JNJ) has a diverse healthcare business, and investors often look to it as a safe dividend stock to invest in for the long term. The company's growth is often in the single digits and with top-selling drug Stelara losing patent protection and its sales already declining, investors are concerned about J&J's long-term growth prospects. On Jan. 13, Johnson & Johnson announced plans to acquire Intra-Cellular Therapies for $14.6 billion.

Motley Fool 8 hours ago

JNJ
Calculating The Intrinsic Value Of Amphenol Corporation (NYSE:APH)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Amphenol fair value estimate is US$64.90 Amphenol's US$70.78...

Simply Wall St. 8 hours ago

APH
3 Dates for Disney Stock Investors to Circle in February

A major financial update, blockbuster Marvel theatrical release, and new Pixar animated series will lead the way this month.

Motley Fool 8 hours ago

DIS
Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock?

Johnson & Johnson (NYSE: JNJ) didn't have an exceptional 2024; in fact, it was one of the worst-performing stocks on the vaunted, 30-company Dow Jones Industrial Average that year. To give some idea of the sheer size of Johnson & Johnson, a glance at its reported sales figure is revealing. It's even more challenging to post any kind of meaningful growth.

Motley Fool 9 hours ago

JNJ
Want $3,000 in Annual Dividends? Invest $17,000 in Each of These 3 High-Yielding Stocks

Collecting dividends on a regular basis is an excellent way to give you some extra savings and strengthen your financial position. There are many dividend stocks to choose from, but finding ones that offer high yields and are safe can be challenging. Three stocks that look safe and may be ideal options to consider right now are Vici Properties (NYSE: VICI), Enbridge (NYSE: ENB), and Ford Motor Company (NYSE: F).

Motley Fool 11 hours ago

EBGEF

F

VICI
Why Johnson & Johnson (JNJ) Is Among the Best Long Term Low Risk Stocks to Buy Now

We recently compiled a list of the 12 Best Long Term Low Risk Stocks to Buy Right Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other long term low risk stocks. As the DeepSeek craze ignites a sell-off in the tech sector, investors are […]

Insider Monkey 12 hours ago

JNJ
DeepSeek Arrived. America Freaked. What Happens Now?

On Jan. 20, when the leaders of America’s most powerful tech companies gathered in Washington, D.C., for the inauguration of President Trump, a startup called DeepSeek released its latest AI model. It was comparable to models released by leading U.S. companies only a few months ago, except it was built with less computing power at a much lower cost—and it came from China.

The Wall Street Journal 18 hours ago

XOM

KO

NKE
Once-popular restaurant chain goes viral for surprising reason

The restaurant chain has become TikTok viral.

TheStreet 21 hours ago

EAT
Altria Is the New Dividend Leader in the S&P 500. Shares Yield Nearly 8%.

Altria became the index’s dividend leader on Thursday, after struggling Walgreens Boots Alliance suspended its payout that same day, citing an effort to improve its balance sheet. While Altria’s dividend payout ratio is high at about 80%—more than double that of the S&P 500—the company takes its dividend very seriously, having raised it in August for the 59th time in 55 years. Altria is a king among S&P dividend aristocrats.

Barrons.com 22 hours ago

MO

^GSPC

LYB
Top Research Reports for NVIDIA, Johnson & Johnson and T-Mobile

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Johnson & Johnson (JNJ) and T-Mobile US, Inc. (TMUS), as well as a micro-cap stock The Eastern Company (EML).

Zacks 22 hours ago

JNJ

NVDA

TMUS
US government could seek over $1 billion from J&J for cancer treatment costs

The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal health agencies' payments of medical costs for patients who allege that the company's baby powder and other talc products caused them to develop cancer, a government attorney said Friday. HHS and the Department of Veterans Affairs recently objected to J&J’s $10 billion proposed settlement of tens of thousands of ovarian cancer lawsuits, saying that resolving those cases in bankruptcy could impair the government's reimbursement rights. Bethany Theriot, a U.S. Justice Department attorney representing the two agencies, said that HHS alone could seek $1.1 billion under the Medicare Secondary Payer law, which allows federal health agencies to seek reimbursement from other parties that are primarily responsible for health care costs incurred by the government.

Reuters 22 hours ago

JNJ
FCC Requests ‘60 Minutes’ Harris Interview Material as It Reviews Paramount-Skydance Merger

The government has asked for the footage and transcript from the segment, which is the subject of a lawsuit against CBS by President Trump, according to people familiar with the situation.

The Wall Street Journal 23 hours ago

DIS

PARA

PARAA

Performance Overview

Return	ALNMR.PA	CAC 40
YTD	+10.33%	+8.70%
1-Year	-61.06%	+3.55%
3-Year	-94.46%	+14.13%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

namR Société anonyme (ALNMR.PA)

Related News

Tariffs, Amazon earnings, Jobs data: What to Watch next week

3 Reasons to Buy Dollar General Stock Like There's No Tomorrow

Could Buying fuboTV Stock Today Set You Up for Life?

What Analysts Think of Disney Stock Ahead of Earnings

Altria Group price target lowered to $53 from $54 at Morgan Stanley

3 Top Dividend Stocks I Plan to Buy in My Retirement Account in February

Is Johnson & Johnson (JNJ) the Best Defensive Stock to Buy Right Now?

A Look At The Fair Value Of The Walt Disney Company (NYSE:DIS)

Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around?

Calculating The Intrinsic Value Of Amphenol Corporation (NYSE:APH)

3 Dates for Disney Stock Investors to Circle in February

Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock?

Want $3,000 in Annual Dividends? Invest $17,000 in Each of These 3 High-Yielding Stocks

Why Johnson & Johnson (JNJ) Is Among the Best Long Term Low Risk Stocks to Buy Now

DeepSeek Arrived. America Freaked. What Happens Now?

Once-popular restaurant chain goes viral for surprising reason

Altria Is the New Dividend Leader in the S&P 500. Shares Yield Nearly 8%.

Top Research Reports for NVIDIA, Johnson & Johnson and T-Mobile

US government could seek over $1 billion from J&J for cancer treatment costs

FCC Requests ‘60 Minutes’ Harris Interview Material as It Reviews Paramount-Skydance Merger

Performance Overview